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Polyclonal ntibodies were raised against two synthetic peptides from different parts of the predicted amino acid sequence 
of the mouse homologue (MBK1) of the Drosophila Shaker K+ channel. The antibodies recognized the toxin-binding 
subunit of the dendrotoxin-binding proteins from rat and bovine brain. The results uggest that the dendrotoxin-binding 
protein is related to the expression products of the mammalian homologue f the Shaker gene. 
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1. INTRODUCTION 
K ÷ channels have been difficult to study due to 
their great variety and low abundance. The sugges- 
tion that the Drosophila Shaker locus might encode 
a voltage-dependent K + channel [1] initiated the 
isolation of the Shaker gene [2,3]. With this genetic 
approach a family of Shaker K ÷ channels were 
identified and characterized [4-8]. Sequences from 
the Drosophila Shaker locus were used to isolate 
related cDNAs from mammalian brain libraries 
[9,10]. These mammalian cDNAs predicted chan- 
nel proteins of approx. 56 kDa [9,10]. 
A parallel biochemical approach to voltage- 
dependent K ÷ channels made use of dendrotoxin 
(DTX), fl-bungarotoxin and mast cell degranu- 
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lating peptide (MCD). These neurotoxins have 
been shown to block specifically a class of neuronal 
voltage-dependent K ÷ channels [11,12]. The 
physiological importance of these channels is 
highlighted by the potent epileptogenicity of the 
toxins [13] and by the ability of MCD to induce 
hippocampal long-term potentiation [14]. DTX, 
MCD and/?-bungarotoxin bind to a brain mem- 
brane protein [15-20] which is most likely identical 
with the K ÷ channels that are physiologically 
blocked by the toxins [16,21]. This protein was 
recently purified from rat brain and named DMB 
protein [from D (DTX), M (MCD), B (fl-bungaro- 
toxin or binding)] [22,23]. DMB protein turned out 
to be a family of pharmacologically and struc- 
turally closely related proteins [23] which consist of 
at least two types of subunits of apparent 
molecular masses 80 and 38 kDa [22,23]. The 80 
kDa subunit binds the toxin, and is glycosylated 
[19,24,25]; deglycosylation reduces its molecular 
mass to 65 kDa [25]. Because the voltage- 
dependent K ÷ channels of the genetic and the 
biochemical approaches had similar molecular 
masses, we investigated the immunological rela- 
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tionship between DMB protein and the mammalian 
Shaker K + channel. 
2. MATERIALS AND METHODS 
2.1. Materials 
DMB protein was purified from Triton X-100 extracts of rat 
and bovine brain membranes in three successive steps as de- 
scribed in [22]: ion-exchange chromatography was followed by 
affinity chromatography on a DTX~ column and then affinity 
chromatography on a wheat germ agglutinin column. Elution of
DMB protein from the DTXt affinity column was accomplished 
with 0.7 M KCl. This method has the advantage over the recent- 
ly reported elution of DMB protein with dithiothreitol [26] in 
that the DTXt affinity column can be used repeatedly and is 
stable for several months. DTX~, a member of the dendrotoxin 
family of neurotoxins, was purified from D. polylebis venom 
(Sigma) according to [27]. Goat anti-rabbit IgG antibody 
coupled to alkaline phosphatase was obtained from Sigma. 
Neuraminidase from Arthrobacter ureafasciens and glycopep- 
tidase F from Flavobacterium meningosepticum were from 
Boehringer, Mannheim. 
2.2. Preparation of antibodies 
Two peptides predicted by a mouse K + channel cDNA clone 
(MBKI) [9] were chemically synthesized and purified by HPLC 
(peptide I, amino acids 1-27, N-terminal end; peptide II; amino 
acids 443-470 near the C-terminal end; see fig.2). The peptides 
were conjugated tokeyhole limpet hemocyanin [28]. Polyclonal 
antibodies against this conjugate were raised in rabbits by 
Berkeley Antibody Co. (Richmond, CA). The titer of the an- 
tisera was evaluated by ELISA and dot-blot echniques for the 
conjugated peptides and by immunoblotting for the toxin- 
binding subunit of DMB protein. Using antibody dilutions from 
1 : 50 to 1 : 1000, the antibodies against peptide I did not cross- 
react with peptide II and vice versa. 
2.3. SDS-PAGE and immunoblots 
Aliquots from various teps in the DMB protein purification 
were precipitated according to [29] and analyzed on 8 or 10070 
SDS-PAGE [30]. The proteins of the gel were either silver- 
stained [31] or electrotransferred onto nitrocellulose [32]. After 
staining for protein with Ponceau S, the blots were blocked and 
incubated with one of the anti-MBKl antibodies (dilutions 
1 : 50-1 : 1000). Blots were developed with a goat-anti-rabbit IgG 
coupled to alkaline phosphatase (dilution 1 : 3000). 
2.4. Deglycosylation 
For treatment with neuraminidase and glycopeptidase F, 
DMB protein was precipitated according to [29] and resolubi- 
lized in 0.1070 (w/v) SDS at 95°C. After addition of Triton 
X-100 (final concentration 0.2070, w/v) and dithiothreitol (final 
concentration 7 mg/ml) the samples were incubated with neur- 
aminidase alone or neuraminidase followed by glycopeptidase F 
as described in [25]. Enzyme reactions were stopped with 
Laemmli sample buffer. 
3. RESULTS AND DISCUSSION 
DMB protein was purified from bovine brain us- 
ing a protocol identical to that used for DMB pro- 
tein from the rat [22]. In both species DMB protein 
was composed of at least two types of subunits. 
The toxin-binding subunit of the bovine DMB pro- 
tein had an apparent molecular mass of 74 kDa in 
8070 SDS-PAGE (fig.l). The apparent molecular 
mass of the toxin-binding subunit of DMB protein 
in SDS-PAGE depended on the percentage of 
acrylamide used [25]. For the rat, it was 80 kDa in 
8070 SDS-PAGE and 90 kDa in 10°70 SDS-PAGE; 
for the bovine form it was 74 and 83 kDa, respec- 
tively ([25]; not shown). No difference between the 
two species was observed for the molecular mass of 
the 38 kDa subunits. In fig.1 some proteolytic 
breakdown products of the 38 kDa subunits can be 
observed which also seem to be identical between 
the two species. Purified DMB protein of both 
species contained in addition to the 38 kDa subunit 
small and variable amounts of a peptide of 40 kDa. 
Using a slightly different protocol DMB protein 
from bovine brain was also purified by Parcej and 
Dolly ([26] and see section 2). In agreement with 
our results, a toxin-binding subunit of 75 kDa and 
small subunits of 37 and 42 kDa were found in 8% 
SDS-PAGE. 
Polyclonal antibodies were raised against two 
synthetic peptides (designated I and II) from the 
1 2 M 
Fig. 1. Silver-stained 8070 SDS-PAGE with purified bovine DMB 
protein (lane 1,180 ng) and rat DMB protein (lane 2, 60 rig). (M) 
Molecular mass markers (in kDa): phosphorylase b (97.4), 
bovine serum albumin (66.2) and ovalbumin (42.7). The posi- 
tions of the toxin-binding subunits are indicated by arrowheads. 
The 38 kDa subunits are marked by black circles (e). 
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predicted amino acid sequence of the mouse MBK 1 
K + channel [9] (fig.2). In immunoblots of pure 
bovine and rat DMB protein, antibodies against 
both peptides recognized the toxin-binding sub- 
units of 74 and 80 kDa, respectively (fig.3). The 
low molecular mass band which is faintly recogniz- 
ed by antibodies against peptide I (fig.3, lane 2) is 
probably a degradation product of the toxin- 
binding subunit and not he 38 kDa subunit as the 
latter has a slightly higher molecular mass and it is 
better focussed. The antibodies were used to follow 
the purification of DMB protein. Very little im- 
munostaining was seen with the initial Triton 
X-100 extract of the brain membranes orafter ion- 
extrecellulor 
V '  cooH 
Fig.2. Model of the transmembrane structure of the MBKI  
Shaker K + channel protein. The positions of two potential in- 
tracellular phosphorylation sites (P), the $4 voltage sensor 
( + + + + + ) and a potential extraceUular glycosylation site (*) 
are indicated. Bold lines (I and II) indicate the peptides used for 
Rntihcldv nranaration. 
exchange chromatography, the latter estimated to 
yield a 10-fold purified preparation (fig.4 and not 
shown). This highlights the low abundance of 
DMB protein in brain (200-400 fmol/mg mem- 
brane protein) [15,16,19] and the specificity of the 
antibodies. Specific immunostaining of the toxin- 
binding subunit was first prominent in blots of the 
eluate from the DTXI affinity column (fig.3, lane 
1). No immunostaining was seen with the break- 
through of the DTXI column, even when large 
amounts of protein were loaded (fig.5, lane 7). 
Thus, all detectable immunoreactivity seems to be 
retained on the DTX~ affinity column, suggesting 
that the mammalian Shaker K + channels are in- 
cluded in the DMB protein family. 
The difference in molecular mass of the toxin- 
binding subunits between the rat and bovine pro- 
A 
1 2 3 
..... 1 . . . .  
Fig.3. Immunoblots from 8070 SDS-PAGE of partialy purified 
bovine DMB protein: eluate from the DTXI affinity column 
(lane 1: 2/~g protein), purified bovine DMB protein (lanes 2,3,5; 
0.5, 0.5 and 0.4~g protein, respectively) and purified rat DMB 
protein (lane 4, 0.1 /~g protein). Incubation performed with 
(lanes): antibodies against peptide I; (3) preimmune serum, (5) 
antibodies against peptide II as described in section 2. Molecular 
masses (in kDa) are indicated. 
B 
97.4 
66.2 
42.7 
31.0 
Fig.4. Immunoblot from 10070 SDS-PAGE of Triton X-100 ex- 
tract of bovine brain membranes (lane 1), purified bovine DMB 
protein (lane 2) and rat brain membranes (lane 3). (A) Protein 
pattern (Ponceau S staining), (B) immunostaining with anti- 
bodies against peptide I. Both panels show the same blot. 
Molecular masses (in kDa) are indicated. 
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Fig.5. Immunoblot from 10% SDS PAGE of eluate (lanes 1-6, 
2/zg protein per lane) andbreakthrough (lane 7, 60/Lg protein) 
of the DTX~ affinity column. The eluate was reated with 
neuraminidase for 5 rain (lane 2), 20 min (lane 3), or 90 min 
(lanes 4-6) and subsequently with glycopeptidase F for 20 min 
(lane 5) or 60 rain (lane 6) as described in section 2. No enzyme 
treatment (control) in ane 1. The blot was developed with an- 
tibodies against peptide I. Molecular masses (in kDa) are in- 
dicated. 
tein seems, at least partially, to be due to differen- 
tial glycosylation. Treatment with neuraminidase 
reduces the molecular mass of the toxin-binding 
subunit  of bovine DMB protein from 83 to 66 kDa 
in 10070 SDS-PAGE (fig.5). Similar results were ob- 
tained with the toxin-binding subunit  of rat DMB 
protein [25]. In contrast o the rat, however, the 
molecular mass of bovine toxin-binding subunit  
was not further reduced by an addit ional treatment 
with glycopeptidase F (fig.5), indicating a different 
structure of its sugar chain. 
We have shown here that the purif ication 
method devised for rat DMB protein is applicable 
to DMB protein from other mammals.  Apart  from 
differential glycosylation, there may be little dif- 
ference between mammal ian  DMB proteins. The 
major  conclusion of this paper is that a strong im- 
munological  relationship exists between DMB pro- 
tein and the mammal ian  homologue of the Droso- 
phila Shaker K + channels. This conclusion is sup- 
ported by the recent f inding that DTX and MCD 
block K + currents induced in Xenopus oocytes by 
rat Shaker mRNA [33]. We suggest that some 
members of the DMB protein family are products 
of the mammal ian  homologue of the Drosophila 
Shaker gene. 
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